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Abstract
Background: Chlamydiae produce a set of proteins, termed Inc proteins, that are localized to the
inclusion membrane and exposed to the host cell cytosol. Little information exists regarding the
interaction of Inc proteins with the eukaryotic cell. To examine these interactions, Vaccinia virus
vectors and mammalian plasmid-based systems were used to express inc genes in mammalian cells.
Results:  Cells transfected with plasmids expressing Chlamydophila caviae incA were not
productively infected by C. caviae. Expression of C. caviae incA also reduced inclusion formation by
Chlamydia trachomatis, but not to the degree seen for C. caviae. Chlamydia trachomatis incA did not
block development of either C. trachomatis or  C. caviae. Deletion mutagenesis was used to
demonstrate that plasmids encoding either the amino or carboxy-terminal regions of the protein,
as well as the changing of a single amino acid within IncA (serine 17) could not block C. caviae
infection. Immunoblot analysis of truncated IncA in a Vaccinia virus system provided evidence that
serine 17 of C. caviae IncA is a target for phosphorylation.
Conclusions: These experiments provide insight into the interaction of Inc proteins with the host
cell and introduce a model system where these interactions can be explored further.
Background
The obligately intracellular chlamydiae occupy a nonacid-
ified vacuole (the inclusion) as they grow and divide
within infected cells [1]. These bacteria produce a set of
inclusion proteins (Inc proteins) that are secreted and
localized to the inclusion membrane [2-6]. At least ten Inc
proteins have been identified and it is likely that many
more Inc proteins are produced by chlamydiae [7].
The analysis of Inc protein structure and function is hin-
dered by the absence of a system for genetically transform-
ing chlamydiae. However, some progress has been made
recently using alternate approaches. Microinjection stud-
ies demonstrated that Inc proteins contact the host cell
cytosol, and that selected Inc proteins are phosphorylated,
likely by host cell protein phosphokinases [4,8]. Two-
hybrid analysis demonstrated that C. trachomatis IncA
dimerizes, and microinjection of antibody directed at this
protein blocks fusion of inclusions [9]. Two-hybrid anal-
ysis also showed that IncG interacts with a host cell pro-
tein (14-3-3β), and that phosphorylation of IncG is
required to facilitate this interaction [8]. These results
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support a hypothesis that places Inc proteins at a central
point in the interaction between the host cell and the
intracellular, intravacuolar chlamydial developmental
forms.
In this study we examined the effects on host cells of plas-
mid- or virus- encoded IncA or IncA-fragments (Fig. 1),
either in the presence or absence of a chlamydial infec-
tion. We demonstrate that expression of full length C. cav-
iae incA completely blocks the development of C. caviae
and partially blocks development of C. trachomatis.
Results
Cytosolic expression of C. caviae incA blocks C. caviae 
development
Plasmids encoding C. caviae and C. trachomatis IncA were
transfected into HeLa cells and the resulting effects on cel-
lular morphology were examined using fluorescence
microscopy. IncA was distributed to discrete regions
throughout the cytosol but the cell morphology was not
affected (Fig. 2a). However, cells expressing C. caviae incA
were refractory to productive infection by C. caviae (Fig.
2b, Fig. 3). These data were expressed quantitatively by
examining the percentage of transfected cells that con-
tained chlamydial inclusions (Fig. 4). Plasmid-driven
Schematic representations of inc gene constructs used in this study Figure 1
Schematic representations of inc gene constructs used in this study. The plasmid name (left) and a schematic of the predicted 
protein structure (center), and oligonucleotides used in construction (right; Table 1) are indicated for each plasmid. The scale 
bar at top indicates the length in amino acids of each predicted gene product. All pcDNA4/HisMax C constructs encode a pol-
yhistidine tag at the amino terminus. Chlamydophila caviae and C. trachomatis incA were also expressed via pcDNA3.1(+), in con-
structs that do not encode proteins with a polyhistidine tag. A large region of predicted hydrophobicity within each predicted 
protein is indicated for each construct (darker bar).BMC Microbiology 2004, 4:24 http://www.biomedcentral.com/1471-2180/4/24
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Effect of cytosolic expression of incA and incC from C. caviae or C. trachomatis Figure 2
Effect of cytosolic expression of incA and incC from C. caviae or C. trachomatis. The vector pcDNA4/HisMaxC was used in each 
construct examined in this figure. IncA was detected by using specific monoclonal antibodies and labeled in red in each panel. 
Distribution of His/IncC fusion protein in the cytoplasm was detected indirectly by using anti polyhistidine tag monoclonal anti-
bodies (Clontech) and also labeled in red. In panels B-F, the nuclei are labeled with DAPI (blue) and chlamydiae are labeled with 
anti-HSP60 (green). Panel A; HeLa cell transfected with pCcAWT (C. caviae incA). Panel B; HeLa cell transfected with pCcAWT 
in a monolayer subsequently infected at an MOI of 1.0 with C. caviae. Panel C; HeLa cell transfected with pCcAWT and subse-
quently infected at an MOI of 0.25 with C. trachomatis. Panel D; HeLa cell transfected with pCtAWT and subsequently infected 
at an MOI of 0.25 with C. trachomatis. Panel E; HeLa cell transfected with pCtAWT and subsequently infected at an MOI of 0.25 
with C. caviae. Panel F; HeLa cell transfected with pCcCWT (C. caviae incC) and infected with C. caviae at MOI 1.0. The scale bar 
in F indicates 8 microns for each panel.BMC Microbiology 2004, 4:24 http://www.biomedcentral.com/1471-2180/4/24
Page 4 of 10
(page number not for citation purposes)
expression of C. caviae incA led to a marked reduction in
the number of inclusions formed within cells (P < 0.01
against any other tested plasmid), and the very few inclu-
sions that can be identified in these transfected cells are
morphologically aberrant (Fig. 3). This aberrancy is man-
ifested as larger than normal reticulate bodies, with single
chlamydial developmental forms occupying individual
vacuoles within cells [10]. This is in contrast to inclusions
formed in nontransfected cells or cells transfected with
any other plasmid produced for this work (Fig. 2, 3). Plas-
mid-driven expression of C. caviae incA also caused a sta-
tistically significant reduction in inclusion formation by
C. trachomatis (P < 0.05: Fig. 4), but did not lead to mor-
phological aberrancy of the C. trachomatis inclusions and
developmental forms (Fig. 2c). The developmental block
is specific to transfection with plasmids expressing C. cav-
iae incA, as transfected cells producing C. trachomatis IncA
showed no qualitative (Fig. 2d,2e) or quantitative (Fig. 4)
difference in inclusion formation by either species.
The developmental block observed for C. caviae incA was
not host-cell type specific. Each of the transfection/infec-
tion experiments was repeated in ChoK1 cells with similar
results (not shown).
Plasmid pcDNA4/HisMaxC encoding chlamydial IncC
were also used in the transfection/infection experiments.
Expression of incC from C. caviae (Fig. 2f) or C. trachomatis
(not shown) did not block chlamydial development but
this expression led to the formation of an extensive net-
work of plasma membrane extensions at the surface of
transfected cells.
Examples of aberrant C. caviae inclusions formed in cells transfected with pcDN3.1(+) encoding C. caviae IncA Figure 3
Examples of aberrant C. caviae inclusions formed in cells transfected with pcDN3.1(+) encoding C. caviae IncA. IncA is labeled 
green and chlamydial HSP60 is labeled yellow/orange in this image. Aberrant inclusions within transfected HeLa cells are shown 
with white arrowheads. A typical C. caviae inclusion within a nontransfected cell is shown in the low right corner of the figure 
(arrow). Cells were infected at a MOI of 0.5 and fixed with methanol 30 h post infection. The scale bar indicates 10 microns.BMC Microbiology 2004, 4:24 http://www.biomedcentral.com/1471-2180/4/24
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Analyses were then conducted to identify regions of C.
caviae  IncA that might be important in facilitating the
developmental block within these cells. Expression plas-
mids were constructed that encoded amino- and carboxy-
terminal deletions of IncA (Fig. 1). None of the truncated
forms of C. caviae IncA blocks development of C. caviae
(Fig. 5b,5c. Fig. 4a: P values greater than 0.2). A final con-
struct was examined that encoded full length C. caviae
IncA with a single changed amino acid residue, a serine to
alanine mutation at position 17 (pCcAS17A). Transfec-
tion with pCcAS17A also failed to block development of
C. caviae (Fig. 5a) and led to similar numbers of infected/
transfected cells, as did controls (Fig. 4a). Therefore
changes as small as a single amino acid abrogated the abil-
ity of IncA to block subsequent C. caviae development.
In previous work we showed that phosphorylation of IncA
was associated with an electrophoretic mobility shift
resulting in two additional protein species at a higher
apparent molecular mass in polyacrylamide gels [4]. For
our initial analyses of the site of phosphorylation in IncA,
a truncated incA sequence was engineered into Vaccinia
virus (VV) and the encoded protein was examined by
immunoblotting of infected cell lysates. These experi-
ments demonstrated that a polypeptide containing the
amino terminal 153 amino acids of C. caviae IncA was
modified in HeLa cells similarly to that seen with the full-
length protein (Fig. 6). Site-directed mutagenesis of serine
or threonine codons in the truncated incA were conducted
to examine the effect of individual amino acid changes on
the migration of the protein. Altering serine 17 resulted in
the elimination of the highest of the three electrophoretic
species seen in immunoblots of VV-infected cells (Fig. 6).
These results were consistent in three independent con-
structs that altered either serine 17 alone or serine 16 and
17 in combination (data not shown). Changes at any
other serine or threonine in the amino terminal 153
amino acids of C. caviae IncA did not alter on the migra-
Quantitative analysis of transfection/infection experiments Figure 4
Quantitative analysis of transfection/infection experiments. The data shown represents the number of infected and transfected 
cells per one hundred transfected cells in the population. In all cases, cells to be used for quantification were infected at an MOI 
of 1 and were fixed for microscopy at 24 h post-infection. The error bars indicate standard deviations. Panel A; The relative 
infection efficiency of cells transfected with plasmids carrying each of the truncated or S17A mutated genes of C. caviae shown 
in Fig. 1 and Fig. 5, as compared to transfection with a plasmid expressing wild type (WT) of C. caviae incA. Panel B; Percent of 
cells infected with C. trachomatis (shown as C.t.) and C. caviae (shown as C.c.) after transfection with plasmids expressing either 
C. caviae or C. trachomatis incA (pCcAWT and pCtAWT, respectively).BMC Microbiology 2004, 4:24 http://www.biomedcentral.com/1471-2180/4/24
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tion pattern of the protein in this assay. These results
suggest that C. caviae IncA is phosphorylated at serine 17
in the VV expression system.
Discussion
Although several Inc proteins have been identified in each
of three different chlamydial species, their role in chlamy-
dial biology is poorly understood. Inc proteins are present
at the cytoplasmic face of the inclusion and likely are crit-
ical for direct interactions with proteins in the host cell
cytosol [4,8,9]. The study of Inc proteins is complicated by
their overall lack of sequence identity with proteins in the
sequence databases and the absence of a system for
directed mutagenesis in the chlamydiae. We used plas-
mid- or virus-driven expression systems to localize
chlamydial Inc proteins into the cytosol of mammalian
cells, and to examine the resulting phenotypes either in
the presence or absence of a chlamydial infection. Similar
approaches have been used to examine proteins secreted
by other pathogens into the cytosol of infected cells
[11,12].
The primary focus of this work was to examine the utility
of plasmid-driven expression of chlamydial inc genes to
deliver Inc proteins to the cytosol of host cells. These
experiments were initially designed to determine if IncA
could be localized to the inclusion membrane after pro-
duction in the host cell cytosol. It should be noted that we
were unable to deliver an Inc protein to the inclusion
membrane using this technique (not shown). However,
these experiments allowed the analysis of cellular pheno-
types associated with the cytosolic expression of incA or
incC. First, we determined that cells transfected with C.
caviae incA were refractory to productive infection by C.
caviae. These results were demonstrated qualitatively and
quantitatively, and the experiments were independently
repeated with two plasmid constructs. The observed
developmental block was specific to C. caviae incA; C. tra-
chomatis incA had no affect in this system. The differences
in effect by these two genes is not surprising, as their pre-
dicted protein sequences share only 20% identity
[3,13,14].
All chlamydial Inc proteins contain a large hydrophobic
motif within the coding sequence. As high level expres-
sion of foreign hydrophobic proteins can be toxic to cells
we included a second Inc protein (IncC) as a control in
these experiments. Although production of IncC from C.
caviae (Fig. 2b) or C. trachomatis (not shown) altered cell
structure significantly, expression of incC in this system
had no effect on chlamydial development. Therefore the
described block in C. caviae and C. trachomatis develop-
ment was specifically a function of the production of C.
caviae IncA.
Effect of cytosolic expression of deleted or mutated C. caviae  incA sequences Figure 5
Effect of cytosolic expression of deleted or mutated C. caviae 
incA sequences. Cells were transfected with either 
pCcAS17A, which encodes a protein differing from wild type 
at only a single amino acid (panel A), pCcAm2, which 
encodes a protein lacking the amino terminal 60 amino acids 
of IncA, (panel B), or pCcAM3, which encodes a protein lack-
ing the carboxy terminal 116 amino acids of IncA (panel C). 
The fluorescence images are labeled with anti-polyhistidine 
monoclonal antibody (red), and anti-chlamydial HSP60 
(green). The nuclei are labeled with DAPI (blue). The scale 
bar in C indicates 8 microns for each panel.BMC Microbiology 2004, 4:24 http://www.biomedcentral.com/1471-2180/4/24
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Immunoblots of lysates of HeLa cells infected with different Vaccinia virus (VV) recombinants Figure 6
Immunoblots of lysates of HeLa cells infected with different Vaccinia virus (VV) recombinants. Full length (lanes 1 and 2) and 
truncated (lanes 5–8) IncA bands are indicated with brackets. Control VV-infected cells are in lane 3 and uninfected cells are in 
lane 4. As previously reported [4,8], full length C. caviae IncA migrates as three isoforms when produced during chlamydial 
infection (lane 1) or when expressed via a VV vector (lane 2). Lane 8 shows that truncated wild type IncA (residues 1 to 153) 
encoded by VV also is represented as three similar isoforms. Mutation of serines or threonines in the truncated incA are repre-
sented in lanes 5 (S17A), lane 6 (S121A) and lane 7 (T145A). Molecular mass standards are indicated in kilodaltons. The arrow 
indicates a background VV band recognized by the anti-incA antisera in some samples.BMC Microbiology 2004, 4:24 http://www.biomedcentral.com/1471-2180/4/24
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We observed that, in the few transfected cells that con-
tained inclusions, development of C. caviae was univer-
sally aberrant. These results suggest that the reduction in
titer is a result of interfering with development, as
opposed to interfering with attachment. If the block was
associated with attachment, it is likely that some normal
C. caviae development would have been observed in the
few inclusions within C. caviae incA-transfected cells.
Deletion mutagenesis was used to examine the region of
C. caviae IncA responsible for blocking C. caviae develop-
ment. No truncated fragment of IncA affected the subse-
quent ability of C. caviae to infect transfected cells. The
abrogation of the ability of incA expression to block C.
caviae development was observed with changes to IncA
sequence at the single amino acid level. A modification of
serine 17 was sufficient to remove the developmental
block observed with the wild type gene. The mechanism
of this block is not known, but we hypothesize that IncA
encoded by the transfected plasmid serves as a competi-
tive inhibitor for some host cell molecule critical for C.
caviae development. We also hypothesize that the proper
phosphorylation state of IncA is required to facilitate this
interaction. Through the use of the VV expression system,
we provide data suggesting that C. caviae IncA is phospho-
rylated at that residue, but further experimentation in this
area will be required. The importance of the phosphoryla-
tion state of an inclusion membrane protein has previ-
ously been demonstrated for the interaction of C.
trachomatis IncG with host cell 14-3-3β [8].
The results we observed with the C. caviae transgene are
analogous to the data in which the effects on chlamydial
growth of a dominant negative dynamin transgene were
examined [15]. Dynamin participates in both endocytosis
and vesicle trafficking within cells [16], and it is possible
that IncA and dynamin affect single process that leads to
the lack of productive development by C. caviae [17].
Many intracellular microbes use diverse mechanisms to
parasitize the host cell [18]. The intracellular, intravacu-
olar parasites, including the chlamydiae, interact with the
cytosolic compartment at many levels. The localization of
Inc proteins at the surface of the inclusion supports a
hypothesis that these proteins are important in the cell
biology of host cell-chlamydia interactions. We anticipate
that the model systems utilized in this work, in concert
with other approaches, will be useful for the elucidation
of the intracellular biology associated with chlamydial
development.
Conclusions
1. Plasmid-driven expression of C. caviae incA in mamma-
lian cells blocked productive C. caviae infection. C. caviae
incA also reduced the ability of C. trachomatis to infect cells
2. C. trachomatis incA had no effect on C. caviae or C. tra-
chomatis infection.
3. Alterations of C. caviae incA sequence as small as a sin-
gle amino acid abrogated the blocking effect.
Methods
Chlamydial strains, host cell lines, and chlamydial 
infections
Chlamydia trachomatis strain 434/Bu (serovar L2) and C.
caviae strain GPIC elementary bodies were purified from
infected monolayers by passage over a 30% Hypaque
density gradient. Purified chlamydiae were stored in 0.25
M sucrose, 10 mM sodium phosphate, 5 mM L-glutamic
acid (SPG) at -80°C prior to use [19]. HeLa and ChoK1
cells (ATCC) were cultured in Minimal Essential Medium
supplemented with 10% fetal bovine serum (Gibco) and
10 µgml-1 gentamicin and grown at 37°C in 5% CO2. Ele-
mentary bodies diluted in SPG were added to the cells at
multiplicities of infection (MOI) as indicated. Infected
cells were centrifuged at 500 g for 1 h at room temperature
(RT), after which the inocula were removed, the cells were
washed with Hank's Balanced Salt Solution (Gibco) and
medium was added.
Cells to be used for microscopic analysis were cultured on
sterile glass coverslips at 50 to 80% confluency. After 30–
35 h, infected cells were fixed in 100% methanol for 10
min and washed with phosphate-buffered saline (PBS).
Cells were then subjected to fluorescent antibody staining
or stored at 4°C.
Vaccinia virus recombinants
Full length C. caviae incA and a truncated incA fragment
(nucleotides 1–459) were amplified using Pwo polymer-
ase (Boehringer). Terminal oligonucleotide primers
(Table 1; see additional file 1) were designed to yield
restriction enzyme sites for cloning into plasmid pRB21, a
shuttle vector that allows simple selection of VV
recombinants [4]. Alanine substitutions of serine or thre-
onine residues in IncA were produced using a three-
primer technique [20]. All amplification products were
confirmed by DNA sequencing. Recombinant Vaccinia
virus diluted in PBS were inoculated onto HeLa cells and
incubated at room temperature for 1 h prior to addition
of MEM-10 and incubation at 37°C [4]. Production of
IncA and the identification of different IncA isoforms were
monitored by immunoblot analysis of VV-infected HeLa
cell lysates collected 16 hours post-infection [4].
Construction of plasmids used in transfection experiments
Plasmids pcDNA3.1(+) and pcDNA4/HisMax C (Invitro-
gen) were used as vectors in all experiments (Fig. 1). Plas-
mid pcDNA4/HisMax C vector encodes a polyhistidine
tag that was fused to the amino terminus of eachBMC Microbiology 2004, 4:24 http://www.biomedcentral.com/1471-2180/4/24
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recombinant polypeptide. Intact or truncated coding
regions of C. caviae incA, or incC, and C. trachomatis incA,
were amplified using primers indicated in Table 1. Restric-
tion sites for EcoRI and EcoRV were introduced into the
forward and reverse primers, respectively, for each ampli-
fication product to be cloned. Reactions were carried out
using Pwo polymerase and chlamydial genomic DNA as
template. Plasmids from positive clones were purified
(Qiagen) and confirmed by sequence analysis.
Antibodies and Immunofluorescence Microscopy
Monoclonal antibody A57B9, directed at a genus com-
mon epitope on chlamydial GroEL (HSP60), was used to
label chlamydial developmental forms [21]. Polyclonal
anti-IncA was produced as described [13]. Monoclonal
antibodies to C. trachomatis IncA (mAb 3H7) or to C. cav-
iae  IncA (mAb 17F12) have been previously described
[4,22]. Monoclonal antibody to polyhistidine was pur-
chased from Clontech.
Fixed monolayers were incubated in 2% bovine serum
albumin in PBS (BSA-PBS), as a blocking reagent, for 20
min. Primary antibodies diluted in BSA-PBS were then
incubated on cells for 1 h. Cells were washed three times
with PBS and then incubated in the dark with the appro-
priate secondary antibodies for 1 h. Secondary antibodies
were purchased from Southern Biotechnology Associates.
The cells were washed three times in PBS and coverslips
were inverted onto 3 µl of Vectashield (Vectors Laborato-
ries) containing the DNA-specific fluorochrome 4', 6'-
diamino-2-phenylindole (DAPI; Sigma; 2 µgml-1).
Labeled monolayers were examined at 1000× magnifica-
tion using a Leica fluorescence microscope and images
were collected with a SPOT digital camera system (Diag-
nostic Instruments). Images were processed in Photoshop
5.0 (Adobe Software) and Canvas 6 (Deneba Software).
Transfections and transfection/infection experiments
HeLa or ChoK1 cells grown on sterile glass coverslips were
transfected with the indicated plasmid constructs using
Lipofectamine 2000 (Gibco) according to manufacturer's
instructions. All quantitative infection/transfection analy-
ses were conducted in cells with MOI of 1. Transfected
cells were incubated 24 h post transfection and then either
fixed with methanol or infected with chlamydiae. Infected
cells were incubated 30 h prior to methanol fixation,
unless indicated. The efficiency of infection of transfected
cells was determined by labeling inclusions with anti-pol-
yhistidine (to detect the product of the transgene) and
anti-HSP60 (to detect the chlamydiae). Following labe-
ling, coverslips were removed and the infection rates
determined by counting infected and transfected cells,
and total numbers of transfected cells, under 1000×
magnification.
In experiments where HeLa cells were doubly transfected
with plasmids expressing incA and incC, a pcDNA3.1(+)
construct encoding IncA in the absence of the 6-his tag
was used in combination with pcDNA4/HisMax C encod-
ing IncC. Cells were transfected as described and exam-
ined by fluorescence microscopy, using anti-IncA and
anti-6-His reagents to detect IncA and IncC, respectively.
Statistical analysis
Standard deviations were calculated for each combination
of plasmid and chlamydial strain from the average of two
or three wells in the same experiment. The number of
transfected cells that were infected by chlamydiae in a par-
ticular experiment was evaluated in at least three inde-
pendent experiments for each plasmid construct tested. A
total of at least 300 individual transfected cells were
counted for each tested plasmid construct. In each case,
the significance of the differences between means were
evaluated using both the Student's T test and the Kruskall-
Wallis test, as calculated using the Instat software program
(GraphPad Software). Reported P values represent calcu-
lations based on the Student's T test.
Abbreviations
VV – Vaccinia virus
GPIC – Guinea Pig Inclusion Conjunctivitis
SPG – Solution of 0.25 M sucrose, 10 mM sodium phos-
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MOI – Multiplicity of Infection
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PBS – Phosphate-Buffered Saline
MEM-10 – Minimum Essential Medium with 10% fetus
bovine serum
mAb – Monoclonal antibodies
BSA – Bovine Serum Albumin
DAPI – 4', 6'-diamino-2-phenylindole
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